{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:43:00Z","timestamp":1754484180495,"version":"3.37.3"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238476","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T17:46:24Z","timestamp":1599068784000},"page":"e0238476","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-4794","authenticated-orcid":true,"given":"Kathiaja Miranda","family":"Souza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Maia","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Lovato Pires de","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9lio Gomes Ribeiro","family":"Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-264X","authenticated-orcid":true,"given":"Isabella de Figueiredo","family":"Zuppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Alvares","family":"Teodoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco de Assis","family":"Acurcio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro Nagib","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto Afonso Guerra","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"issue":"4","key":"pone.0238476.ref001","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ncl.2016.06.016","article-title":"Epidemiology of Multiple Sclerosis","volume":"34","author":"J Howard","year":"2016","journal-title":"Neurol Clin"},{"issue":"3","key":"pone.0238476.ref002","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: The 2013 revisions","volume":"83","author":"FD Lublin","year":"2014","journal-title":"Neurology"},{"issue":"9648","key":"pone.0238476.ref003","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"A Compston","year":"2008","journal-title":"Lancet"},{"volume-title":"2013: Mapping Multiple Sclerosis Around the World","year":"2013","author":"MS Atlas of","key":"pone.0238476.ref004"},{"issue":"6","key":"pone.0238476.ref005","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.msard.2015.08.004","article-title":"Prevalence of multiple sclerosis in Brazil: A systematic review","volume":"4","author":"A Beatriz","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"pone.0238476.ref006","unstructured":"ABEM. O que \u00e9 Esclerose M\u00faltipla? Associa\u00e7\u00e3o Brasileira de Esclerose M\u00faltipla; 2016. [Cited 2019 November 19]. Available from: http:\/\/abem.org.br\/esclerose\/o-que-e-esclerose-multipla\/"},{"issue":"1\u20133","key":"pone.0238476.ref007","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12026-015-8719-0","article-title":"Advancing drug delivery systems for the treatment of multiple sclerosis","volume":"63","author":"I Tabansky","year":"2015","journal-title":"Immunol Res"},{"key":"pone.0238476.ref008","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"G Giovannoni","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"pone.0238476.ref009","first-page":"40","volume-title":"Portaria n\u00b0 391, de 05 de maio de 2015. Di\u00e1rio Oficial da Uni\u00e3o","author":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade, Minist\u00e9rio da Sa\u00fade, Rep\u00fablica Federativa do Brasil","year":"2015"},{"issue":"2","key":"pone.0238476.ref010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0266462317000423","article-title":"Health technology performance assessment: Real-world evidence for public healthcare sustainability","volume":"33","author":"AA Guerra Junior","year":"2017","journal-title":"Int J Technol Assess Health Care"},{"issue":"9","key":"pone.0238476.ref011","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jama.2018.10136","article-title":"Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness","volume":"320","author":"J Corrigan-Curay","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"pone.0238476.ref012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13311-015-0412-4","article-title":"Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis","volume":"13","author":"J Ingwersen","year":"2016","journal-title":"Neurotherapeutics"},{"key":"pone.0238476.ref013","unstructured":"CONITEC. Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no SUS. Recomenda\u00e7\u00f5es da CONITEC [Internet]. [cited 2019 November 2019]. Available from: http:\/\/conitec.gov.br\/index.php\/decisoes-sobre-incorporacoes"},{"key":"pone.0238476.ref014","first-page":"50","volume-title":"Instituto de Pesquisa Econ\u00f4mica Aplicada, Minist\u00e9rio do Planejamento, Desenvolvimento e Gest\u00e3o","author":"FS Vieira","year":"2017"},{"issue":"1","key":"pone.0238476.ref015","article-title":"Building the National Database of Health Centered on the Individual: Administrative and Epidemiological Record Linkage\u2014Brazil, 2000\u20132015","volume":"3","author":"AA Guerra J\u00fanior","year":"2018","journal-title":"Int J Popul Data Sci"},{"issue":"1","key":"pone.0238476.ref016","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S0102-30982007000100010","article-title":"A constru\u00e7\u00e3o da base de dados nacional em Terapia Renal Substitutiva (TRS) centrada no indiv\u00edduo: aplica\u00e7\u00e3o do m\u00e9todo de linkage determin\u00edstico-probabil\u00edstico","volume":"24","author":"ML Cherchiglia","year":"2007","journal-title":"Rev Bras Estud Popul"},{"issue":"9779","key":"pone.0238476.ref017","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(11)60054-8","article-title":"The Brazilian health system: History, advances, and challenges","volume":"377","author":"J Paim","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"pone.0238476.ref018","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/acr.22840","article-title":"Medication Persistence of Disease-Modifying Antirheumatic Drugs and Anti\u2013Tumor Necrosis Factor Agents in a Cohort of Patients With Rheumatoid Arthritis in Brazil","volume":"68","author":"FA Acurcio","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"6","key":"pone.0238476.ref019","doi-asserted-by":"crossref","first-page":"e0199446","DOI":"10.1371\/journal.pone.0199446","article-title":"The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil","volume":"13","author":"IM Diniz","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"pone.0238476.ref020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.clinthera.2012.01.006","article-title":"Long-Term Persistence With the Immunomodulatory Drugs for Multiple Sclerosis: A Retrospective Database Study","volume":"34","author":"C Evans","year":"2012","journal-title":"Clin Ther"},{"issue":"11","key":"pone.0238476.ref021","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data","volume":"43","author":"H Quan","year":"2005","journal-title":"Med Care"},{"issue":"18","key":"pone.0238476.ref022","first-page":"1","article-title":"A Step-by-Step Guide to Propensity Score Matching in R Information on the Dataset Used","volume":"19","author":"JJ Randolph","year":"2014","journal-title":"Pract Assessment, Res Eval"},{"issue":"2","key":"pone.0238476.ref023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"PC Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"pone.0238476.ref024","doi-asserted-by":"crossref","DOI":"10.7476\/9788575413029","volume-title":"An\u00e1lise de sobreviv\u00eancia: teoria e aplica\u00e7\u00f5es em sa\u00fade","author":"MS Carvalho","year":"2011","edition":"2"},{"issue":"1","key":"pone.0238476.ref025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery date: A practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc"},{"issue":"3","key":"pone.0238476.ref026","first-page":"112","article-title":"Post-Hoc Comparison in Survival Analysis: An Easy Approach","volume":"5","author":"A Tripathi","year":"2017","journal-title":"J Biosci Med"},{"issue":"9","key":"pone.0238476.ref027","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/1352458514559865","article-title":"Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing\u2013remitting multiple sclerosis","volume":"21","author":"T Kalincik","year":"2014","journal-title":"Mult Scler J"},{"key":"pone.0238476.ref028","first-page":"114","volume-title":"Portaria n\u00b0 97, de 22 de mar\u00e7o de 2001. Di\u00e1rio Oficial da Uni\u00e3o","author":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade, Minist\u00e9rio da Sa\u00fade, Rep\u00fablica Federativa do Brasil","year":"2001"},{"key":"pone.0238476.ref029","first-page":"153","volume-title":"Portaria n\u00b0 493, de 23 de setembro de 2010. Di\u00e1rio Oficial da Uni\u00e3o","author":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade, Minist\u00e9rio da Sa\u00fade, Rep\u00fablica Federativa do Brasil","year":"2010"},{"key":"pone.0238476.ref030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/PPA.S15702","article-title":"Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: A retrospective administrative claims analysis","volume":"5","author":"R Halpern","year":"2011","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"pone.0238476.ref031","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1185\/03007990903554257","article-title":"Persistence and adherence to disease modifying drugs among patients with multiple sclerosis","volume":"26","author":"MW Reynolds","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"pone.0238476.ref032","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview","volume":"21","author":"RA Marrie","year":"2015","journal-title":"Mult Scler J"},{"issue":"8","key":"pone.0238476.ref033","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/1352458508092263","article-title":"Comorbidity, socioeconomic status and multiple sclerosis","volume":"14","author":"RA Marrie","year":"2008","journal-title":"Mult Scler"},{"issue":"1","key":"pone.0238476.ref034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-14-128","article-title":"Physical and mental health comorbidity is common in people with multiple sclerosis: Nationally representative cross-sectional population database analysis","volume":"14","author":"RJ Simpson","year":"2014","journal-title":"BMC Neurol"},{"issue":"22","key":"pone.0238476.ref035","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1212\/WNL.0000000000004686","article-title":"Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study","volume":"89","author":"A Laroni","year":"2017","journal-title":"Neurology"},{"key":"pone.0238476.ref036","first-page":"1","article-title":"Determinants of therapy switch in multiple sclerosis treatment-na\u00efve patients: A real-life study","author":"R Lanzillo","year":"2018","journal-title":"Mult Scler J"},{"issue":"7","key":"pone.0238476.ref037","doi-asserted-by":"crossref","first-page":"545","DOI":"10.12998\/wjcc.v3.i7.545","article-title":"Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?","volume":"3","author":"A Gajofatto","year":"2015","journal-title":"World J Clin Cases"},{"issue":"3","key":"pone.0238476.ref038","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajog.2009.07.061","article-title":"Menstrual cycle-related exacerbation of disease","volume":"202","author":"JA V Pinkerton","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"pone.0238476.ref039","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/1352458515606211","article-title":"Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort","volume":"22","author":"R Bove","year":"2016","journal-title":"Mult Scler"},{"issue":"4","key":"pone.0238476.ref040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0123824","article-title":"Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: An 18-year observational cohort study","volume":"10","author":"S Zhornitsky","year":"2015","journal-title":"PLoS One"},{"issue":"52","key":"pone.0238476.ref041","article-title":"Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: Systematic review and economic evaluation","volume":"21","author":"GJ Melendez-Torres","year":"2017","journal-title":"Health Technol Assess (Rockv)"},{"issue":"9","key":"pone.0238476.ref042","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40263-018-0541-5","article-title":"Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis","volume":"32","author":"RC Lucchetta","year":"2018","journal-title":"CNS Drugs"},{"issue":"9","key":"pone.0238476.ref043","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011381.pub2","article-title":"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis","author":"I Tramacere","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"pone.0238476.ref044","doi-asserted-by":"crossref","first-page":"e59694","DOI":"10.1371\/journal.pone.0059694","article-title":"The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilization Using the MSBase Platform","volume":"8","author":"VG Jokubaitis","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"pone.0238476.ref045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3111\/13696998.2010.527588","article-title":"Medication adherence with disease modifying treatments for multiple sclerosis among US employees","volume":"13","author":"NL Kleinman","year":"2010","journal-title":"J Med Econ"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T02:40:41Z","timestamp":1723516841000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238476"}},"subtitle":[],"editor":[{"given":"Sreeram V.","family":"Ramagopalan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238476","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}